Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Fluconazole and Sphingosine 1-Phosphate

Research Papers that Mention the Interaction

FLCZ exhibits potent antifungal activities against Candida spp.,
The Japanese journal of antibiotics  •  1993  |  View Paper
However, the wide use of fluconazole as a first-line antifungal therapy has led to the development of resistance in clinical isolates of Candida species including Candida albicans and the emerging non-albicans Candida spp.
European journal of medicinal chemistry  •  2019  |  View Paper
There was a moderate correlation between the fluconazole MICs for Candida spp.
Journal de mycologie medicale  •  2018  |  View Paper
Administration of fluconazole was a protective factor for both Candida spp.
Diagnostic microbiology and infectious disease  •  2014  |  View Paper
Azole agents overuse, especially fluconazole , for the treatment and prophylaxis of fungal infections has put selective pressure on Candida spp.
Drugs of today  •  2010  |  View Paper
Our results demonstrated that exposure to fluconazole reduces Candida spp.
These results also suggest that adhesion, even in non‐albicans species, could be factors that, along with predisposing conditions … to the host, determine if an individual will develop disease or remain as a healthy carrier and confirm that fluconazole has an impact in the adherence ability in Candida spp.
Mycoses  •  2007  |  View Paper
Either fluconazole or voriconazole MIC results may serve as surrogate markers to predict the susceptibility of Candida spp.
Journal of Clinical Microbiology  •  2007  |  View Paper
The present study addresses the use of fluconazole as a surrogate marker to predict the susceptibility of Candida spp.
Journal of Clinical Microbiology  •  2006  |  View Paper
Fluconazole may serve as a surrogate marker to predict the susceptibility of Candida spp.
The present study addresses the issue of cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict the susceptibility of Candida spp.
Journal of Clinical Microbiology  •  2004  |  View Paper
Show More